Months after its long-awaited physician assistant program was denied provisional accreditation, California State University, San Bernardino has released a response outlining its concerns with the ...

A federal judge granted a temporary restraining order blocking the Department of Health and Human Services from launching its 340B Rebate Model Pilot Program, which was scheduled to begin Jan. 1, 2026 ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — A new program ...

Management of the International Monetary Fund (IMF) has approved the First Review of the Staff-Monitored Program (SMP) with Mali. Program implementation has been broadly satisfactory amid a ...

The U.S. House of Representatives has given a unanimous thumbs-up to the Give Kids A Chance Act, which would revive the FDA’s rare pediatric review voucher program following its expiration in December ...

As the FDA's Commissioner's National Priority Voucher (CNPV) program has picked up steam, with 15 companies now having secured ultrafast drug reviews, questions and criticisms about the initiative ...

Pennsylvania Western University has reshaped its programming for students who enter college without a major — commonly known as “undeclared” or “undecided” students. The university’s new “exploratory ...

International Monetary Fund (IMF) staff and the Malian authorities have concluded the virtual mission under the First Review of the Staff-Monitored Program (SMP), pending approval by IMF management.

A sign that reads “curbside urban oasis” welcomes people walking on Alhambra Boulevard under the Highway 99 underpass on Wednesday, Oct. 5, 2022 as a Sacramento Community Response team talked with ...

The Louisiana Housing Corporation (LHC) will begin accepting applications for the Louisiana Blue Tarp Program - CENLA beginning Monday, November 17, 2025 at 8:00 AM, to Friday, November 21, 2025 at ...

Editor's note: This article has been updated to provide clarity on a head-to-head study Eli Lilly conducted on its candidate, orforglipron. A pill version under development of Novo Nordisk's (NVO) GLP ...